-
2024-517238-16-00
Hypochondroplasia 5 2026-01-28
-
2024-518072-31-00
Achondroplasia 4 2026-01-27
-
2024-516471-33-00
Alport Syndrome 4 2026-01-19
-
2024-519554-37-00
Phenylketonuria 5 2026-01-16
-
2022-501902-36-00
spina bifida 5 2026-01-15
-
2025-520714-63-00
Li-Fraumeni syndrome 5 2026-01-05
-
2024-520130-29-00
Spinal Muscular Atrophy 4 2025-12-17
-
2025-521013-10-00
Treatment of behavioural and cognitive impairments in D 4 2025-12-11
-
2024-519960-42-00
PIK3CA-Related Overgrowth Spectrum (PROS) 4 2025-12-11
-
2023-506290-35-00
Autosomal Dominant Optic Atrophy 1 2025-12-08
-
2025-522719-40-00
CTNNB1 syndrome 7 2025-11-21
-
2024-518895-30-00
PIK3CA Related Overgrowth Spectrum and Malformations Dr 4 2025-11-21
-
2024-515564-32-00
Catecholaminergic Polymorphic Ventricular Tachycardia 4 2025-11-20
-
2023-508785-16-00
Very preterm neonate (gestational age at birth < 32 WG) 5 2025-10-17
-
2023-509175-16-00
Sickle cell disease 5 2025-10-14
-
2025-520490-38-00
Haemophilia A with or without inhibitors. Proposed indi 3 2025-10-13
-
2024-515249-41-00
Cardiorespiratory arrest at birth in full-term newborns 10 2025-10-01
-
2024-516804-40-00
Progressive Familial Intrahepatic Cholestasis 6 2025-09-25
-
2025-521660-35-00
Hereditary Angioedema 5 2025-09-11
-
2025-521455-23-00
Neonatal Hypoxic-Ischemic Encephalopathy (HIE) 3 2025-09-11
-
2024-516822-67-00
Hypochondroplasia 10 2025-08-14
-
2024-516095-15-00
Kidney Disease 1 2025-08-05
-
2024-511702-23-00
Congenital adrenal hyperplasia 4 2025-08-05
-
2024-514846-35-00
CONGENITAL ADRENAL HYPERPLASIA 4 2025-07-22